PI3Ks (phosphoinositide 3-kinases) regulate diverse cellular functions such as metabolism, growth, gene expression and migration. The p110δ isoform of PI3K is mainly expressed in cells of the immune system and contributes to cellular and humoral immunity. In the thymus, p110δ and p110γ play complementary roles in regulating the transition through key developmental checkpoints. In addition, p110δ regulates the differentiation of peripheral Th (helper T-cells) towards the Th1 and Th2 lineages. Moreover, p110δ is critical for Treg (regulatory T-cell) function. Here, we review the role of PI3Ks in T-cell development and function.
Introduction
The TCR (T-cell receptor) triggers sequential activation of the tyrosine kinases Lck and ZAP-70 [ζ -chain (TCR)-associated protein kinase of 70 kDa], which together nucleate and activate a signalling complex composed of the transmembrane adaptor LAT (linker for activation of T-cells), Vav, SLP-76 [SH2 (Src homology 2) domain-containing leucocyte protein of 76 kDa], PLCγ (phospholipase Cγ ), PI3K (phosphoinositide 3-kinase) and other signalling proteins [1, 2] . PLCγ hydrolyses PtdIns(4,5)P 2 to release Ins(1,4,5)P 3 into the cytosol, leaving DAG (diacylglycerol) at the plasma membrane. Increased Ins(1,4,5)P 3 levels lead to a biphasic elevation in the cytosolic calcium concentrations and nuclear translocation of NFAT (nuclear factor of activated T-cells) transcription factors which bind to the promoters of most cytokine genes [3] . DAG activates RasGRP [Ras GRP (guanine nucleotideKey words: colitis, forkhead box O (Foxo), p110δ, phosphoinositide 3-kinase (PI3K), T-cell, thymocyte. Abbreviations used: APC, antigen presenting cell; DAG, diacylglycerol; DN, double negative; DP, double positive; ERK, extracellular-signal-regulated kinase; Foxo, forkhead box O; GPCR, Gprotein-coupled receptor; IL-4, interleukin 4; NF-κB, nuclear factor κB; PH domain, pleckstrin homology domain; PI3K, phosphoinositide 3-kinase; PKB, protein kinase B; PLCγ , phospholipase Cγ ; PTEN, phosphatase and tensin homologue deleted on chromosome 10; RAG, recombinationactivating gene; SH2, Src homology 2; SP, single positive; TCR, T-cell receptor; Treg, regulatory T-cell; WT, wild-type. 1 To whom correspondence should be addressed (email klaus.okkenhaug@bbsrc.ac.uk). releasing protein)], which stimulates the exchange of GDP for GTP on Ras and the consequent activation of the ERK (extracellular-signal-regulated kinase) signalling cascade, which leads to the activation of Fos and other transcription factors. DAG also activates PKCθ (protein kinase Cθ), which activates the NF-κB (nuclear factor κB) signalling pathway via a complex of proteins that regulate IκB (inhibitory κB) kinase activity [4] . PKD (protein kinase D), whose role has yet to be fully defined, but which may be important for chromatin remodelling, is also regulated by DAG [5, 6] . Thus PLCγ activation on its own is sufficient to initiate signalling pathways leading to proliferation and transcriptional activation.
PI3Ks (phosphoinositide 3-kinases) phosphorylate PtdIns(4,5)P 2 to produce PtdIns(3,4,5)P 3 at the plasma membrane. Class IA PI3Ks are recruited to the TCR signalling by a mechanism that has yet to be defined; however, their activation is among the earliest detectable upon T-cell activation [7] [8] [9] [10] . Class IA PI3Ks are composed of one of five regulatory subunits (p85α, p55α, p50α, p85β or p55γ ) attached to one of three catalytic subunits (p110α, p110β or p110δ) [11, 12] . Each regulatory subunit is able to bind to any of the catalytic subunits with equal probability. PI3K signalling is antagonized by the 3-inositol phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) and the 5-inositol phosphatase SHIP (SH2-containing inositol phosphatase). Thus PtdInsP 3 is a short-lived second messenger signalling molecule and continuous signalling input is required to maintain its accumulation at the immune synapse [7, 13] . PDK1 (phosphoinositide-dependent kinase 1), Akt [also known as PKB (protein kinase B)], Itk and various guanine exchange factors have PH domains (pleckstrin homology domains) that bind to PtdInsP 3 . The interaction between PtdInsP 3 and the PH domain can thus lead to the recruitment of signalling proteins to the plasma membrane juxtaposed to their relevant substrates or interaction proteins. In addition, PtdInsP 3 can induce allosteric changes in binding proteins that alter their catalytic activity [14] .
Knockout mice without any p110α or p110β die before birth [15, 16] , which has so far precluded analysis of their roles in immune cell function. In contrast, p110δ expression is largely limited to the immune system and p110δ-deficient mice are viable. To investigate the role of p110δ in immune cell function, a point mutation in the catalytic domain was introduced to produce a kinase-inactive protein (p110δ D910A ) [17] . P110δ has also been inactivated by conventional gene deletion [18, 19] . In T-cells, p110δ is responsible for 50% of p85-associated PI3K activity and appears to be the principal isoform involved in antigen receptor signalling [17, 20] . The Class IB PI3K p110γ subunit, which in contrast with the class IA PI3Ks is regulated by GPCRs (G-protein-coupled receptors), has been targeted by gene deletion and has been shown, in some cases, to contribute to PI3K signalling in concert with p110δ or other class IA PI3Ks in T-cells [21] [22] [23] .
Co-ordinated roles for p110δ and p110γ during thymic selection T-cells are generated in the thymus from bone-marrowderived precursor cells. Progenitor T-cells (thymocytes) are subject to three key selection events referred to as β-selection, positive selection and negative selection. During β-selection, immature CD4 − CD8 − DN (double negative) thymocytes that express functionally recombined TCRβ chain paired with the invariant pre-Tα are selected to become CD4 + CD8 + DP (double positive) cells, at which stage the pre-Tα component is replaced with a TCRα chain [24] . DP thymocytes are next subjected to positive selection by virtue of the binding of the TCRαβ to MHC-peptide complexes; thymocytes that bind MHC class I become CD8
+ SP (single positive) T-cells, whereas thymocytes that bind MHC class II molecules become CD4 + SP T-cells. However, thymocytes that bind MHC-peptide complexes with affinity and/or avidity above a certain threshold are eliminated by apoptosis (negative selection) [25] .
Although β-selection and positive selection appear to be unperturbed in p110δ-deficient mice [17] , p110γ -deficient mice show an increase in numbers of CD4 − CD8 − DN and a moderate reduction in numbers of CD4 + CD8 + DP cells [26, 27] . Strikingly, combined inactivation of p110δ and p110γ leads to a profound additional block at the TCRβ-selection stage with up to 90% reduction in total thymocytes [21, 22] . This effect seems to be through impaired pre-TCR signalling at the CD4 − CD8 − DN stage and increased cell death at the DP stage. Indeed, the expression of the pro-apoptotic protein Bim (Bcl-2-interacting mediator of cell death) was higher in p110γ −/− p110δ −/− CD4 + CD8 + DP thymocytes [21] . The simplest explanation for this redundancy seems to be that TCR-dependent activation of p110δ and GPCR-dependent activation of p110γ co-operate to allow DN thymocytes to develop into DP thymocyte and to promote the survival of the DP thymocytes. Consistent with an important role for PI3K at the β-selection checkpoint, deletion of PTEN allows thymocytes to bypass the β-selection checkpoint without expressing the pre-TCR [28] . Although we have found no evidence for defects in positive selection in p110δ D910A mice, forced activation of PI3K by expressing a truncated p85 regulatory subunit or by interfering with the interaction between p85 and p110 led to increased positive selection of CD4 + SP thymocytes, suggesting that p110α or p110β may play a role in positive selection [26, 29] .
In Balb/c mice, thymocytes expressing the TCR Vβ11 or Vβ12 chains are deleted by the endogenous superantigen Mls [30] . In p110δ D910A mice, deletion of Vβ11 and Vβ12 chains was less effective than in WT (wild-type) mice, indicating that negative selection is impaired in these mice. Selection of Vβ4, which does not bind the Mls superantigen, was unaffected by the p110δ D910A mutation. The decreased negative selection of p110δ-deficient thymocytes may reflect attenuated TCR signalling strength in the absence of p110δ activity and consequent inefficient deletion of autoreactive thymocytes. Curiously, negative selection was also impaired in PTENdeficient thymocytes [31] . In this case, the signal to induce negative selection is probably of sufficient strength, but the absence of PTEN renders the thymocytes more resistant to apoptotic cell death and hence they may escape from the negative selection process.
Regulation of PKB and the Foxo (forkhead box O) transcription factor by p110δ
P110δ-deficient T-cells show decreased proliferation and cytokine production in response to stimulation with antigen, unless given potent CD28 signals provided by an antibody [17] . The decreased proliferation likely reflects delayed cellcycle entry or progression as there was no obvious increase in apoptotic cell death of p110δ D910A T-cells [32] . In response to stimulation of the TCR complex with anti-CD3 antibodies, phosphorylation of PKB, Foxo1/3a and ERK1/2 were reduced [17, 32] . Co-stimulation with anti-CD28 resulted in full ERK1/2 phosphorylation, suggesting that CD28 regulates the Ras signalling pathway independently of p110δ [32] . In contrast, PI3K-dependent phosphorylation of PKB and Foxo1/3a remained attenuated even in the context of CD28 co-stimulation; therefore CD28 does not readily compensate for the loss of p110δ activity by activating p110α or p110β instead [32] . PI3K has also been suggested to be a key regulator of NF-κB in the context of CD28 co-stimulation [33] . Unexpectedly, while we found that CD3-dependent NF-κB nuclear translocation was impaired in p110δ D910A T-cells, this response could be rescued by addition of anti-CD28 [32] . Similarly, the inhibition of PI3K by LY294002 or the p110δ D910A mutation had no effect on p65/ RelA translocation in T-cells stimulated by APCs (antigen presenting cells) and cognate peptide [32] . These results challenge previous studies that proposed a central role for PI3K in the regulation of NF-κB regulation by CD28 [34] [35] [36] . It is currently unclear how we can reconcile our results with these studies. However, the capacity of both p110δ D910A and LY294002-treated cells to translocate p65 to the nucleus in response to TCR/CD28 stimulation does demonstrate that, at least in primary mouse T-cells, there is no absolute requirement for PI3K in regulating TCR/CD28-dependent nuclear translocation of NF-κB.
p110δ regulates T-cell differentiation towards the Th1 and Th2 lineages
After activation, Th (helper T-cells) further differentiate into different Th subsets. The two best characterized of these are the Th1 and Th2 cells which produce the characteristic cytokines IFN-γ (interferon-γ ) and IL-4 (interleukin-4) respectively. Secretion of these cytokines was dramatically reduced in p110δ D910A T-cells [32] . Moreover, the addition of exogenous cytokines failed to rescue the capacity of p110δ D910A cells to differentiate along the Th1 or Th2 lineages. Th differentiation processes require the cells to undergo multiple divisions to successfully remodel the chromatin at their cytokine loci during which the Th1 locus is closed down and the Th2 locus opened, or vice versa [37, 38] . Thus p110δ appears to control a developmental programme that directs T-cells to differentiate to Th1 or Th2 cells. PI3K signalling also leads to the phosphorylation and nuclear exclusion of the transcription factor Foxo [10, 32, 39] . Foxo acts in part by inducing genes that promote cell-cycle arrest or apoptosis or that suppress cellular differentiation [40] . Consistent with a key role for Foxo in suppressing Th1 and Th2 differentiation is the observation that Foxo3a-deficient mice develop autoimmunity associated with the expansion of these T-cell subsets [41] . Hence, one key role of p110δ in T-cells may be to inactivate Foxo transcription factors that maintain T-cells in an undifferentiated state.
p110δ controls the development and function of Tregs (regulatory T-cells)

p110δ
D910A mice develop inflammation of the lower intestine characteristic of a mild form of colitis [17] . A similar disease is seen in many mice with impaired development of Tregs [42] . Tregs are members of the CD4 + T-cell linage and express the IL-2Rα chain CD25 and the transcription factor Foxp3. The expression of Foxp3 is thought to be both necessary and sufficient for development and function of Tregs [43, 44] . CD25 + Foxp3 + Treg can either develop in the thymus or Since p110δ is required both for the function of Th and for Treg cell function, p110δ inhibition has the potential both to attenuate and to exacerbate immune responses. The outcome will likely depend on the relative role of the different T-cell subsets as well as other leucocyte subsets in which p110δ plays a role. Thus, while p110δ inhibition may lead to the development of colitis, there is also evidence that p110δ inhibition can attenuate allergic responses [50] [51] [52] . The effect of p110δ in additional disease models still needs to be assessed.
be converted from conventional Th cells in the periphery. Tregs contribute to tolerance against self-or innocuous antigens by suppressing the proliferation and differentiation of conventional T-cells [45] .
In the thymus of p110δ D910A mice there were increased proportions of Foxp3 + Tregs [46] . It has been proposed that some autoreactive thymocytes that do not undergo negative selection can instead be diverted to the Treg lineage [47] . Thus the enhanced proportions of thymic Tregs in p110δ D910A mice may be connected to decreased TCR signalling strength causing some cells that normally would be negatively selected to develop into Tregs instead. By contrast, there was a reduction in the proportions of Foxp3 + cells in all peripheral immune organs studied. This may reflect impaired emigration from the thymus, decreased peripheral conversion of conventional CD25
− T-cells into Foxp3-expressing T-regulatory cells or decreased survival of Tregs in the peripheral lymphoid organs.
In co-culture experiments, p110δ D910A Treg showed decreased capacity to suppress the proliferation of CD4 + CD25 − cells. The extent of this defective suppression was dependent on the stimulation conditions as p110δ D910A cells showed greater inhibitory capacity when stimulated with APCs coated with CD3 than when cultured with anti-CD3-and anti-CD28-coated beads (often referred to as artificial APCs). The reason for this difference is unclear. p110δ D910A
CD4
+ CD25 + Tregs proliferated robustly in response to anti-CD3 and anti-CD28 when IL-2 was added to the medium. IL-2 also stimulates Treg to secrete IL-10 [48] . However, no IL-10 was detected in the supernatant of p110δ D910A Tregs that had been activated in presence of IL-2.
To test whether the reduced function of Tregs could be the cause of colitis in p110δ D910A mice, we employed an experimental model of colitis developed by Fiona Powrie and coworkers [49] . Colitis was induced in RAG1 (recombinationactivating gene 1)-knockout mice by injection with WT CD4 + CD45RB high T-cells. The co-injection of WT Tregs prevented colitis, whereas the co-injection of p110δ D910A Tregulatory cells failed to prevent colitis ( Figure 1 ) [46] . These results suggest that the development of colitis mice may be due to lack of protection by Tregs in p110δ D910A mice.
Conclusions
The PI3K p110δ plays a key role in the context of antigen receptor signalling. The dual impact of p110δ on Th and Treg development and function raises important questions for p110δ as target for small molecule inhibitors. Reducing Th1 and Th2 responses is a goal for many therapeutic programmes seeking to alleviate inflammation and auto-immunity. However, Tregs play a key role in maintaining tolerance to selfantigens and innocuous antigens (e.g. the intestinal flora). Thus the precise balance of attenuation of immune effectors and regulators by p110δ inhibitors needs to be assessed in different preclinical models (Figure 2 ). In this context, it is encouraging to note that both p110δ inhibitors and genetic inactivation result in decreased T-cell-dependent lung inflammation and mast-cell-dependent allergic responses [50] [51] [52] . 
